Evidence map›Paper›PMID 42907972›Full record

ArticleBMC cancer2026

ClinNetDx: a novel explainable ai framework for acute lymphoblastic leukemia detection using multi-modal clinical data.

Muralidhar Muthukumaran, Prabu Selvam, Prasantha Bharathi Dhandapani, Nirmala Veeramani, Rebecca Muhumuza Nalule, Gokulnath Vetrivel, Samy R Mahmoud, Afaf S Alwabli

Abstract read
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Muralidhar MuthukumaranSchool of Computing, SRM Institute of Engineering and Technology Tiruchirappalli, 621105, Tiruchirappalli, India.
Prabu SelvamSchool of Computing, SRM Institute of Engineering and Technology Tiruchirappalli, 621105, Tiruchirappalli, India.
Prasantha Bharathi DhandapaniDepartment of Mathematics, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, Tamil Nadu, India.
Nirmala VeeramaniSchool of Computing, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, Tamil Nadu, 613401, India.
Rebecca Muhumuza NaluleDepartment of Mathematics, Busitema University, Tororo, 236, Uganda. rnalule.sci@busitema.ac.ug.
Gokulnath VetrivelSchool of Computing, SRM Institute of Engineering and Technology Tiruchirappalli, 621105, Tiruchirappalli, India.
Samy R MahmoudGRC Department, Applied College, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
Afaf S AlwabliBiological Sciences Department, College of Science & Arts, King Abdulaziz University, Rabigh Campus, Jeddah, 21589, Saudi Arabia.

Funding

King Abdulaziz University G- 511-662- 1443
6 · The paper itself

Abstract

Early identification of Acute Lymphoblastic Leukemia (ALL) is vital to respond on time; yet, presently existing diagnostic procedures still depend on laboratory knowledge, manual interpretation and many supplementary exams. This paper introduces ClinNetDx, a new hybrid deep learning model for Acute Lymphoblastic Leukaemia prediction that combines a Convolutional Neural Network (CNN) and a Deep Neural Network (DNN) and employs structured blood test data and (optional) medical images to support good health and well-being. The proposed methodology includes a tabular-to-spatial transformation that converts numerical clinical measures into 2D representations, enabling a CNN to learn spatial correlations among features from structured medical data. We use advanced pre-processing methods (normalization, imputation, SMOTE) that are robust to class imbalance and missing variables. For interpretability, we use dual explainability: SHAP values to explain feature contributions for numerical data and Grad-CAM visualizations to generate localized heatmaps for image inputs. To make it accessible in a clinical environment, the system is built as a Django-powered web application that provides on-the-fly predictions and an intuitive presentation of findings. The design is flexible and deployed as a RESTful API for interface with medical information systems, mHealth apps and cloud platforms. To demonstrate the promising predictive and generalizing power of the proposed system, it was evaluated on publicly available multi-modal haematological datasets comprising 5,000 structured CBC records, 2,500 ALL smear images, and 2,000 synchronized multi-modal samples using k-fold cross-validation, with confusion matrices and ROC-AUC reported. Experimental assessment shows that ClinNetDx achieves 98.1% classification accuracy, outperforming conventional machine learning and unimodal deep learning models while maintaining strong precision, recall, and ROC-AUC performance. The proposed system combines accurate multi-modal prediction with interpretable decision support, making it a potential option for computer-assisted early diagnosis of Acute Lymphoblastic Leukaemia and for future clinical decision-support applications.

Indexed as

Deep LearningPrecursor Cell Lymphoblastic Leukemia-LymphomaConvolutional Neural NetworksHumansNeural Networks, ComputerAcute Lymphoblastic LeukemiaConvolutional Neural NetworkDeep LearningEarly DiagnosisGood health and well-beingSHAP Explainability

Identifiers

PMID42907972
PMCPMC13688856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.